Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ji Y. Wu
Down-Regulation of Interleukin-3/Granulocyte-Macrophage Colony-Stimulating Factor Receptor Beta-Chain in BCR-ABL+ Human Leukemic Cells: Association With Loss of Cytokine-Mediated Stat-5 Activation and Protection From Apoptosis After BCR-ABL Inhibition
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
Cancer Research
Cancer Research
Oncology
Related publications
Adaptive Secretion of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Mediates Imatinib and Nilotinib Resistance in BCR/ABL+ Progenitors via JAK-2/STAT-5 Pathway Activation
Blood
Biochemistry
Immunology
Cell Biology
Hematology
BCR-ABL-transformed GMP as Myeloid Leukemic Stem Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Protein Kinase CKIIa Interacts With the BCR Moiety of BCR/Abl and Mediates Proliferation of BCR/Abl-Expressing Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Disruption of the BCR-Abl/Hsp90 Protein Complex: A Possible Mechanism to Inhibit BCR-Abl-Positive Human Leukemic Blasts by Novobiocin
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
MT1-MMP as a Downstream Target of BCR-ABL/ABL Interactor 1 Signaling: Polarized Distribution and Involvement in BCR-ABL-stimulated Leukemic Cell Migration
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Erythropoietin Receptor Haploinsufficiency and in Vivo Interplay With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin 3
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Induction of BCR-ABL-specific Immunity Following Vaccination With Chaperone-Rich Cell Lysates Derived From BCR-ABL+ Tumor Cells
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Retraction Note: Disruption of the BCR-Abl/Hsp90 Protein Complex: A Possible Mechanism to Inhibit BCR-Abl-Positive Human Leukemic Blasts by Novobiocin
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
BCR-ABL Tyrosine Kinase
Science-Business eXchange